Search Results

You are looking at 1 - 1 of 1 items for :

  • molecular markers x
  • 100 Years of the Warburg Effect and Endocrine Cancer x
  • Refine by access: All content x
Clear All
Francesca Ruggieri Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Francesca Ruggieri in
Google Scholar
PubMed
Close
,
Katharina Jonas Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Katharina Jonas in
Google Scholar
PubMed
Close
,
Manuela Ferracin Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy

Search for other papers by Manuela Ferracin in
Google Scholar
PubMed
Close
,
Michael Dengler Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Michael Dengler in
Google Scholar
PubMed
Close
,
Vanessa Jӓger Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Vanessa Jӓger in
Google Scholar
PubMed
Close
, and
Martin Pichler Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Department of Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
Translational Oncology, University Hospital of Augsburg, Augsburg, Germany

Search for other papers by Martin Pichler in
Google Scholar
PubMed
Close

molecular mechanisms ( Fig. 3 ). This regulation depends on cell type, physiological conditions, and external factors. miRNAs are mainly transcribed by RNA polymerase II from intergenic, intronic, or polycistronic loci to long primary transcripts, called pri

Free access